stocks logo

ACOG

Alpha Cognition Inc
$
5.660
-0.47(-7.667%)1D
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
5.970
Open
5.650
VWAP
5.78
Vol
67.96K
Mkt Cap
128.13M
Low
5.600
Amount
392.65K
EV/EBITDA(TTM)
--
Total Shares
20.90M
EV
88.72M
EV/OCF(TTM)
--
P/S(TTM)
--
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.
Show More
AI Stock Picker
1 Analyst Rating
Wall Street analysts forecast ACOG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACOG is 18.00 USD with a low forecast of 18.00 USD and a high forecast of 18.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 5.660
sliders
Low
18.00
Averages
18.00
High
18.00
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$20 -> $18
2025-10-20
Reason
H.C. Wainwright lowered the firm's price target on Alpha Cognition to $18 from $20 and keeps a Buy rating on the shares after the sale of roughly 4.6M shares of common stock and approximately 949,000 pre-funded warrants to purchase common stock at a price of $6.25 per share earlier this month. The firm is trimming its 12-month price target to account for the equity dilution from the recent financing as well as revisions to its sales forecasts.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Alpha Cognition Inc (ACOG.O) is -3.90, compared to its 5-year average forward P/E of -5.24. For a more detailed relative valuation and DCF analysis to assess Alpha Cognition Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-5.24
Current PE
-3.90
Overvalued PE
-2.69
Undervalued PE
-7.78

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.84
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
3.73
Undervalued EV/EBITDA
-2.05

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
11.01
Current PS
6.13
Overvalued PS
17.78
Undervalued PS
4.24
Financial AI Agent

Financials

Annual
Quarterly
FY2025Q2
1.66M
Total Revenue
FY2025Q2
YoY :
+139.03%
-5.74M
Operating Profit
FY2025Q2
YoY :
+395.81%
-10.49M
Net Income after Tax
FY2025Q2
YoY :
+85.71%
-0.65
EPS - Diluted
FY2025Q2
-6.15M
Free Cash Flow
FY2025Q2
67.78
Gross Profit Margin - %
FY2025Q2
-632.75
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
47.9K
Volume
Months
0-12
2
538.6K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Intellectia AI SwingMax

ACOG News & Events

Events Timeline

2025-10-01 (ET)
2025-10-01
05:44:40
Alpha Cognition Prices 5.6M Share Spot Secondary Offering at $6.25
select
2025-09-30 (ET)
2025-09-30
16:59:09
Alpha Cognition Reveals Common Stock Offering, Amount Not Disclosed
select
2025-07-29 (ET)
2025-07-29
08:58:44
Alpha Cognition announces CMS Zunveyl NDA accepted for review by NMPA
select
Sign Up For More Events

News

9.5
00:00 AMNASDAQ.COM
PinnedAlpha Cognition Inc. (ACOG) Announces Q3 Loss While Exceeding Revenue Projections
3.0
11-12NASDAQ.COM
MDT Q2 Earnings Outlook: Cardiovascular Division Expected to Drive Growth
4.0
10-21NASDAQ.COM
HC Wainwright & Co. Reaffirms Buy Rating for Alpha Cognition (ACOG)
Sign Up For More News

FAQ

arrow icon

What is Alpha Cognition Inc (ACOG) stock price today?

The current price of ACOG is 5.66 USD — it has decreased -7.67 % in the last trading day.

arrow icon

What is Alpha Cognition Inc (ACOG)'s business?

arrow icon

What is the price predicton of ACOG Stock?

arrow icon

What is Alpha Cognition Inc (ACOG)'s revenue for the last quarter?

arrow icon

What is Alpha Cognition Inc (ACOG)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Alpha Cognition Inc (ACOG)'s fundamentals?

arrow icon

How many employees does Alpha Cognition Inc (ACOG). have?

arrow icon

What is Alpha Cognition Inc (ACOG) market cap?